BioCentury
ARTICLE | Clinical News

Actelion announces positive Phase III data

May 2, 2000 7:00 AM UTC

Actelion (SWX:ATLN) said it showed that treatment with its bosentan improved hemodynamics and increased exercise capacity in advanced pulmonary hypertension patients. The international, double-blind s...